These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 18506890)
1. Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration. Aram G; Potter JJ; Liu X; Torbenson MS; Mezey E Hepatology; 2008 Jun; 47(6):2051-8. PubMed ID: 18506890 [TBL] [Abstract][Full Text] [Related]
2. Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration. Aram G; Potter JJ; Liu X; Wang L; Torbenson MS; Mezey E Hepatology; 2009 Mar; 49(3):911-9. PubMed ID: 19072832 [TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase is not essential for the development of fibrosis and liver damage induced by CCl4 in mice. Moreno MG; Muriel P J Appl Toxicol; 2006; 26(4):326-32. PubMed ID: 16705756 [TBL] [Abstract][Full Text] [Related]
4. Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1. Peng WH; Tien YC; Huang CY; Huang TH; Liao JC; Kuo CL; Lin YC J Ethnopharmacol; 2010 Feb; 127(3):606-13. PubMed ID: 20035854 [TBL] [Abstract][Full Text] [Related]
5. Disruption of tissue-type plasminogen activator gene in mice aggravated liver fibrosis. Hsiao Y; Zou T; Ling CC; Hu H; Tao XM; Song HY J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e258-64. PubMed ID: 17944888 [TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats]. Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562 [TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Yoshiji H; Kuriyama S; Miyamoto Y; Thorgeirsson UP; Gomez DE; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Tsujinoue H; Nakatani T; Thorgeirsson SS; Fukui H Hepatology; 2000 Dec; 32(6):1248-54. PubMed ID: 11093731 [TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis. Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026 [TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells. Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. Rabani V; Shahsavani M; Gharavi M; Piryaei A; Azhdari Z; Baharvand H Cell Biol Int; 2010 Apr; 34(6):601-5. PubMed ID: 20178458 [TBL] [Abstract][Full Text] [Related]
13. Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl₄-treated mice. Manuelpillai U; Tchongue J; Lourensz D; Vaghjiani V; Samuel CS; Liu A; Williams ED; Sievert W Cell Transplant; 2010; 19(9):1157-68. PubMed ID: 20447339 [TBL] [Abstract][Full Text] [Related]
14. Influences of reactive oxygen species and nitric oxide on hepatic fibrogenesis. Novitskiy G; Potter JJ; Wang L; Mezey E Liver Int; 2006 Dec; 26(10):1248-57. PubMed ID: 17105591 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of gallic acid on CCl4-mediated liver fibrosis in mice. Wang J; Tang L; White J; Fang J Cell Biochem Biophys; 2014 May; 69(1):21-6. PubMed ID: 24096707 [TBL] [Abstract][Full Text] [Related]
16. Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Parsons CJ; Bradford BU; Pan CQ; Cheung E; Schauer M; Knorr A; Krebs B; Kraft S; Zahn S; Brocks B; Feirt N; Mei B; Cho MS; Ramamoorthi R; Roldan G; Ng P; Lum P; Hirth-Dietrich C; Tomkinson A; Brenner DA Hepatology; 2004 Nov; 40(5):1106-15. PubMed ID: 15389776 [TBL] [Abstract][Full Text] [Related]
17. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells. Suárez-Cuenca JA; Chagoya de Sánchez V; Aranda-Fraustro A; Sánchez-Sevilla L; Martínez-Pérez L; Hernández-Muñoz R Exp Biol Med (Maywood); 2008 Jul; 233(7):827-39. PubMed ID: 18445764 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of olive oil on fibrosis induced by carbon tetrachloride in rat liver. Fang HL; Lai JT; Lin WC Clin Nutr; 2008 Dec; 27(6):900-7. PubMed ID: 18824281 [TBL] [Abstract][Full Text] [Related]
19. Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice. Onozuka I; Kakinuma S; Kamiya A; Miyoshi M; Sakamoto N; Kiyohashi K; Watanabe T; Funaoka Y; Ueyama M; Nakagawa M; Koshikawa N; Seiki M; Nakauchi H; Watanabe M Biochem Biophys Res Commun; 2011 Mar; 406(1):134-40. PubMed ID: 21300023 [TBL] [Abstract][Full Text] [Related]
20. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Shi H; Dong L; Jiang J; Zhao J; Zhao G; Dang X; Lu X; Jia M Toxicology; 2013 Jan; 303():107-14. PubMed ID: 23146752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]